Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases.
about
Hepatitis C Virus, Insulin Resistance, and SteatosisType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightAssessing cardiovascular risk in hepatitis C: An unmet needSteatosis and hepatitis CFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVEnvironmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions.Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study.Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital.Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.New insights into HCV-related rheumatologic disorders: A review.A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesChronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection.Metabolic reprogramming: a hallmark of viral oncogenesis.Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin.Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease.Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review.Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment.Mental and physical health-related quality of life in patients with hepatitis C is related to baseline comorbidities and improves only marginally with hepatitis C cure.Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formationChronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
P2860
Q26751755-0A8EEEE5-DFF7-45C1-A07A-4A7F26B355C1Q26752583-9231AEB3-9BF2-45D7-B1C0-F8C7BA14A223Q26784258-81CA36FF-D317-47DB-8834-839E02042CBFQ26798101-7CE833D6-32AE-4ED4-96AB-9537533644C4Q28079826-AEED8288-D2A9-457E-A899-3824C1F2A60BQ33916655-43A8E178-D23D-427B-A1B7-8A11A768A5E3Q35958590-B7D012B8-A988-4E73-8A74-BA655E5AE4B3Q36183998-B6061C77-75E4-43F9-A9FA-AA3601B53BEEQ36311785-0BCC8718-E72A-4B85-8530-932412082DB7Q37006223-F528A5AB-D0DA-448D-9D37-C0AB10566D8BQ37328614-E6452FFB-C69C-408D-A795-0FF28374B94CQ37374053-C45295F3-E2CD-4AC8-A215-119368136321Q37610871-035BBA80-9C50-4C82-BE8B-24D289BCC705Q37703437-39257156-BF1D-4782-9432-CE885C7253E7Q38638110-DC4D3001-2A7F-4F7D-8F90-AF4BA2DAAA75Q38656396-0853D00B-8842-476F-84FD-225D1E775171Q38674284-E222136E-67FC-4419-91F2-04FD1BCFD9DCQ38689700-C4DEEB9A-2EB4-4887-96FB-642B584F4B46Q38702378-DCA43104-3D1B-4091-8883-6979C0430A5FQ40051943-40E24972-3821-404D-9E49-9CB8C493707FQ40071098-A277D3B8-6DE2-4396-B8A7-A88AE563AE62Q40167729-912CAC29-DC39-4C64-9C5C-AB8CFA7FB0FFQ40225926-FF924D9E-11BE-446E-B896-649E2E953CD0Q40597591-F8F7010B-3C61-407A-87D8-C120F982D50AQ41372756-0212F51E-4780-4212-BBF3-3BE2E34E5018Q41928201-70AD43CA-7790-40E3-BC04-F8CB4845D09DQ47169604-3E7225C9-9D80-471D-8E7B-6B28B5497783Q47555610-AF5C4FDB-FDB1-4F4A-A3A8-0D9B02B7D22BQ47574522-91964F2E-6242-4BA1-B8DD-1519F6489FFCQ50145783-254DD3DD-8BAD-4386-AB95-BB7DEDE3B783Q55427948-5A3C14D5-618F-47D5-9275-E8C17A4580FEQ58723536-642B42FE-9E22-46B7-B3C0-20B1B527C4C9Q58785077-2A00D112-ECAF-48D5-BB26-C46D0FB2EB77
P2860
Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Facts and fictions of HCV and ...... , and cardiovascular diseases.
@en
type
label
Facts and fictions of HCV and ...... , and cardiovascular diseases.
@en
prefLabel
Facts and fictions of HCV and ...... , and cardiovascular diseases.
@en
P1476
Facts and fictions of HCV and ...... , and cardiovascular diseases.
@en
P2093
Francesco Negro
P304
P356
10.1016/J.JHEP.2014.08.003
P433
P577
2014-11-03T00:00:00Z